Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

38.62 +3.30 (+9.34%)
Streaming Delayed Price Updated: 11:16 AM EST, Jan 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
The 3 Best Med Tech Stocks to Buy Now ↗
Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now. 
Via InvestorPlace
News headline image
Evaluating Twist Bioscience: Insights From 5 Financial Analysts ↗
 
Via Benzinga
News headline image
Key Takeaways From Twist Bioscience Analyst Ratings ↗
 
Via Benzinga
News headline image
Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts ↗
 
Via Benzinga
News headline image
Breaking Down Twist Bioscience: 5 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Beats Q3 Earnings Forecast, Plans To Achieve 50% Gross Margin By Fiscal Year 2025 ↗
Twist Bioscience reported a Q3 adjusted EPS loss of $(0.70), surpassing the $(0.77) consensus. With a net loss of $85.6 million and sales at $81.5 million, Twist Bioscience saw a 27.8% year-over-year... 
Via Benzinga
News headline image
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Biotech Bull Market Is Intact But SMIDs Are Too Volatile ↗
It was another wild week for the market as it had to contend with a lot of news. 
Via Talk Markets
News headline image
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates ↗
In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance. 
Via Benzinga
Topics ETFs
News headline image
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today ↗
 
Via Benzinga
News headline image
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? ↗
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga
News headline image
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
From Twist Bioscience Corporation
Via Business Wire
News headline image
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
From Twist Bioscience Corporation
Via Business Wire
News headline image
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
From Twist Bioscience Corporation
Via Business Wire
News headline image
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. 
Via InvestorPlace
News headline image
Cathie Wood's Ark Invest Purchases Over $30M of Shopify Shares Amid Q1 Numbers-Driven Plunge; Adds Reddit Shares To Kitty — Offloads Coinbase Stock As Bitcoin Declines ↗
On Wednesday, Cathie Wood’s Ark Invest made some significant trades. 
Via Benzinga
News headline image
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cathie Wood's Ark Invest Swoops In To Buy The Palantir Dip — Purchases Stock Worth $29M — Offloads Coinbase Shares Worth Over $15M Amid Softening Bitcoin Price ↗
On Tuesday, the Cathie Wood-led Ark Invest made some significant trades. 
Via Benzinga
News headline image
Genomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says ↗
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.